Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |